Back to Signals

Signal · Frailty

Clinical Frailty Scale predicts outcomes in elderly heart failure patients, meta-analysis confirms

A meta-analysis finds the Clinical Frailty Scale is a validated prognostic tool specifically in elderly heart failure populations, though the finding should not be generalised to non-cardiac frailty pathways.

1 min read Meta-analysis NEW

A meta-analysis examined the Clinical Frailty Scale (CFS) as a prognostic tool specifically in elderly patients with heart failure Meta-analysis (Sebastian & Yehya1, PMID: 42641835).

The finding is condition-specific: it establishes CFS’s prognostic value within a cardiology-frailty population, and should not be read as evidence that CFS performs equivalently across all frailty pathways, or as a general endorsement of CFS over other frailty-assessment tools outside heart failure.

For services managing the interface between cardiology and frailty pathways, the finding supports using CFS as a prognostic marker specifically in elderly heart-failure caseloads.

Sources

  1. Sebastian & Yehya. Clinical Frailty Scale and outcomes in elderly heart failure: a meta-analysis. Current Problems in Cardiology. 2026. doi:10.1016/j.cpcardiol.2026.103432 PMID 42641835